ABSTRACT Histiocytoid Sweet syndrome (H‐SS) is a variant of Sweet syndrome characterized by a dermal infiltrate of immature myeloid cells with histiocytoid morphology rather than mature neutrophils. These cells express myeloid markers including myeloperoxidase, lysozyme, CD15, and CD13. H‐SS has been associated with hematologic malignancies and demonstrates higher relapse rates compared with classic Sweet syndrome. This review synthesizes current evidence on the clinicopathologic features, immunophenotype, disease associations, and treatment of H‐SS, and examines its position within the broader spectrum of myeloid cutaneous infiltrates.
Ava Scott, Emily Smith. Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses. // Journal of Cutaneous Pathology. – 2026. – DOI: 10.1111/cup.70233. – URL: https://onlinelibrary.wiley.com/doi/10.1111/cup.70233?af=R
Ava Scott & Emily Smith (2026). Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70233
Ava Scott and Emily Smith. “Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses.” Journal of Cutaneous Pathology, 2026. doi:10.1111/cup.70233.
@article{Scott2026,
title = {Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses},
author = {Scott, Ava and Smith, Emily},
journal = {Journal of Cutaneous Pathology},
year = {2026},
doi = {10.1111/cup.70233},
url = {https://onlinelibrary.wiley.com/doi/10.1111/cup.70233?af=R}
}
ABSTRACT Angioimmunoblastic T‐cell lymphoma (AITL) is a peripheral T‐cell lymphoma derived from T‐follicular helper cells that frequently exhibits cutaneous involvement with highly variable clinical manifestations. We report a...
Purpose Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X...